← Lookup

UnitedHealthcare (Commercial) · facet joint interventions

v1verified 2026-07-24needs re-verificationmanual-pull source

✓ conditional · commercial

Criteria checklist

0 of 6 ticked
Indications
  • enumerated: yes
  • covered:
      • name: Diagnostic facet / medial branch block (only when RFA is being considered)
      • criteria:
        • pain exacerbated by: facet-loading maneuvers
        • conservative min weeks: 4
        • residual pain: >=3/10 after conservative care
        • imaging ruleout: other causes excluded; segment not fused
        • rfa intent: RFA must be the planned endpoint
  • investigational:
    • THERAPEUTIC facet / medial branch injections (cervical, thoracic, lumbar) — all banned
    • diagnostic blocks used as treatment (no RFA planned)
    • ultrasound guidance
    • blocks with untreated radiculopathy at the same level (except facet synovial cyst)
Conservative care
  • required: yes
  • min duration months: not stated in the policy
  • min duration weeks: 4
  • satisfied by:
    • failed >=4 weeks with residual pain >=3/10
    • contraindicated
  • modalities named:
    • pharmacotherapy
    • physical therapy / home exercise
    • activity modification
Trial
  • required: no
  • min duration days: not stated in the policy
  • success criteria: not stated in the policy
  • threshold is binding: no
Psychological evaluation
  • required: no
  • must clear: no
  • note posture: not required
Diagnostic blocks (facet protocol)
  • required before: radiofrequency neurotomy (governed by the separate UHC ablation policy)
  • relief threshold pct: 50
  • max blocks per level per side: 2
  • anesthetic volume: <=0.5 mL per MBB
Quantity limits
  • applies: yes
  • max diagnostic blocks per level per side: 2
  • note: after 2 blocks at a level/side, further injections are therapeutic = not covered
Payor-specific notes

UHC's facet policy covers ONLY diagnostic medial branch blocks, and only when RFA is the planned endpoint (a positive block = >=50% relief; <=2 blocks per level/side; MBB anesthetic <=0.5 mL). Notably STRICTER than Medicare: UHC deems ALL therapeutic facet/MBB injections unproven (Medicare permits limited therapeutic facet sessions), and bars diagnostics-as-treatment and ultrasound guidance. The facet RFA (neurotomy) coverage itself is in a SEPARATE UHC policy ("Ablative Treatment for Spinal Pain") not captured here — needs_reverification. From the actual fetched UHC PDF.

Ticks are a documentation aid — nothing is stored; they reset on reload.

Dot phrase

Lean narrative A&P attestation. `***` = fill-in. Fully self-contained — rendered from UHC 2026T0004VV. SCOPE: this policy covers DIAGNOSTIC medial branch blocks only, and only with RFA as the planned endpoint; ALL therapeutic facet/MBB injections are not covered. The RFA itself is governed by the separate UHC "Ablative Treatment for Spinal Pain" policy (not restated here).

.FACETUHC
.FACETUHC

Assessment: *** — suspected facet-mediated *** (cervical / thoracic / lumbar) pain,
exacerbated by facet-loading maneuvers, with other causes excluded on imaging. The index
segment is not fused and there is no untreated radiculopathy at the same level (facet
synovial cyst excepted).

Medical necessity per UHC 2026T0004VV: conservative care has failed or was contraindicated
over >=4 weeks — pharmacotherapy, physical therapy or home exercise, and activity
modification: *** — with residual pain >=3/10. I am proceeding with a diagnostic medial
branch block (64490-64495) with radiofrequency ablation as the planned endpoint, using
<=0.5 mL of anesthetic per block; a positive block is >=50% relief lasting at least the
duration of the anesthetic used. This falls within the limit of <=2 diagnostic blocks per
level and side. Guidance is fluoroscopic or CT; ultrasound is not covered.

Plan: Diagnostic medial branch block at level(s) and side ***, date ***. If positive, RFA
will follow under the separate UHC "Ablative Treatment for Spinal Pain" policy. Risks,
benefits, and alternatives discussed; consent obtained.

Where this payor diverges from the Medicare baseline

  • scope (diagnostic blocks ONLY; facet RFA lives in a separate UHC ablation policy)
  • diagnosis line (facet-loading maneuvers + imaging rule-out)
  • conservative-care line (>=4 wk floor with residual pain >=3/10)
  • diagnostic-block line (>=50% positivity; <=0.5 mL; <=2 per level/side)
  • therapeutic-injection ban (all regions)

Cautions

  • Beyond 2 blocks per level/side the injections count as THERAPEUTIC and are not covered. Therapeutic facet/MBB injections in all regions, and diagnostic blocks used as treatment, are unproven / not covered. Confirm the separate ablation policy's gates before scheduling RFA. Prior auth: not stated in this policy — check the separate UHC Advance Notification / Prior Authorization list. Regenerate if `uhc-commercial-facet-joint.md` `version` advances past `source_version`.

Prior-auth pathway

  • required: not stated in the policy
  • note: not stated in-policy; governed by a separate UHC Advance Notification / Prior Authorization list

Provenance

  • authority:
    • type: commercial_policy
    • id: UHC 2026T0004VV
    • title: Facet Joint and Medial Branch Block Injections for Spinal Pain — Commercial and Individual Exchange
    • applies because: UHC commercial medical policy governs facet diagnostic blocks; facet RFA/ablation is governed by a SEPARATE UHC policy (Ablative Treatment for Spinal Pain)
  • source: https://www.uhcprovider.com/content/dam/provider/docs/public/policies/comm-medical-drug/facet-joint-injections-spinal-pain.pdf
  • archived copy: sources/uhc_facet_2026-05-01.pdf (sha256 228fbbe75c5a… — kept in the content repo, not served here)
  • effective: 2026-05-01 · payor last reviewed: 2026-05-01 · we verified: 2026-07-24 · v1

Report an issue with this cell

Change history

  • 2026-07-24commercial cells: re-verify 27 source PDFs by SHA-256 (Carelon/eviCore/UHC/Cigna) - all unchanged vs committed archive; last_verified -> 2026-07-24 3615c231f0
  • 2026-06-30Archive commercial source PDFs into sources/ + wire source_file/source_hash c5466694c8
  • 2026-06-28Add commercial Facet Joint cells: Anthem(Carelon), UHC, Cigna(eviCore) 962ec9816b